On April 5, 2011, Dr. Covert, a psychiatrist in Houston, Texas, attended an important continuing psychiatric education event. The speaker was William M. Glazer, M.D., who has been a member of both the Yale and Harvard Medical School psychiatric faculties.
Dr. Glazer spoke on the topic of “Management of Bipolar I or Schizophrenic Patients.” He discussed salience, the ability to focus attention on what is important, often missing in these disorders. The efficacy of asenapine in these disorders was discussed by the local psychiatrists and residents attending. The comparative advantage of this relatively new medication was efficacy, but also a reduced incidence of tardive dyskinesia, hyperlipidemia, weight gain and akasthesia as well as dystonia.
Posted on 4-5-2011
